Literature DB >> 3407160

Delta hepatitis in Denver.

W G Rector, S Govindarajan, K A Penley, F N Judson.   

Abstract

The prevalence of hepatitis D virus (HDV) infection in patients with hepatitis B virus (HBV) infection in the mid-United States is not well defined. We tested 65 patients seen between 1983 and 1986 with HBV infection in Denver for evidence of coexisting HDV infection. Five patients had anti-delta (delta) antibody. The prevalence of HDV infection was higher in patients with chronic hepatitis B (4/37) than in patients with acute hepatitis B (1/28). The prevalence of HDV infection in male homosexuals (3/32) was similar to reported figures, but the incidence of delta-infection in intravenous drug users in Denver was usually low (1/16). In comparison to Los Angeles, New York, southern Italy, and Sweden, Denver appears to have a low incidence of HDV infection, which probably reflects its low prevalence in the drug-using population.

Entities:  

Mesh:

Year:  1988        PMID: 3407160      PMCID: PMC1026242     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  26 in total

1.  Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study.

Authors:  K M DeCock; B Jones; S Govindarajan; A G Redeker
Journal:  West J Med       Date:  1988-03

2.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

3.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

6.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

7.  Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

Authors:  A Smedile; C Lavarini; P Farci; S Aricò; G Marinucci; P Dentico; G Giuliani; A Cargnel; C Del Vecchio Blanco; M Rizzetto
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

8.  Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.

Authors:  M T Schreeder; S E Thompson; S C Hadler; K R Berquist; A Zaidi; J E Maynard; D Ostrow; F N Judson; E H Braff; T Nylund; J N Moore; P Gardner; I L Doto; G Reynolds
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

9.  Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.

Authors:  A Smedile; C Lavarini; O Crivelli; G Raimondo; M Fassone; M Rizzetto
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

10.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

View more
  1 in total

Review 1.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.